Target Healthcare REIT (LON:THRL) Hits New 12-Month High – Time to Buy?

Posted by Jeff Wilder on Feb 3rd, 2026

Shares of Target Healthcare REIT (LON:THRL – Get Free Report) reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as GBX 107 and last traded at GBX 105.80, with a volume of 43040 shares traded. The stock had previously closed at GBX 105.60.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group increased their price target on Target Healthcare REIT from GBX 99 to GBX 101 and gave the stock a “buy” rating in a report on Tuesday, October 28th. One analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of GBX 101.

View Our Latest Research Report on THRL

Target Healthcare REIT Trading Up 0.8%

The company has a quick ratio of 1.52, a current ratio of 7.20 and a debt-to-equity ratio of 34.92. The company has a market capitalization of £660.38 million, a P/E ratio of 10.85, a P/E/G ratio of 1.48 and a beta of 0.44. The firm’s 50-day moving average price is GBX 98.76 and its 200 day moving average price is GBX 97.10.

About Target Healthcare REIT

(Get Free Report)

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.